Gold falls as dollar rebounds, investors eye U.S. stimulus

* "Blue wave" likely to lift gold prices - analyst

* Interactive graphic tracking global spread of coronavirus: Link (Updates prices)

By Eileen Soreng

Oct 13 (Reuters) - Gold edged lower on Tuesday as the dollar rebounded, although the metal is likely to be supported going forward due to an eventual U.S. stimulus package that will boost its appeal as a hedge against the resultant inflation.

Spot gold XAU= inched 0.1% lower to $1,919.76 per ounce by 0813 GMT.

U.S. gold futures GCv1 were down 0.3% at $1,922.70 per ounce.

"In the absence of further dollar downside, gold bulls are feeling a little jittery at the moment," said Howie Lee, an economist at OCBC Bank.

"Over the near or longer term, there is a boost for gold prices if it is (stimulus) passed. But because we're stuck in a deadlock now and it increasingly looks like there'll be none before the elections, gold is struggling a bit here."

The dollar index .DXY was up 0.2% against rivals.

A White House spokeswoman said on Monday Senate Republicans will go along with what President Donald Trump wants in a coronavirus relief legislation.

Trump on Sunday called on Congress to pass a stripped-down bill.

Investors also kept close tabs on the upcoming U.S. elections with polls showing Democrat rival Joe Biden leading the race.

"A so-called 'blue wave' would likely pave the way for a larger fiscal support package, which in turn could exert more upward pressure on bullion," said FXTM market analyst Han Tan.

"A protracted delay to the U.S. elections outcome could also spur risk aversion in the interim, which could buffer the supportive environment for gold," Tan said, adding, however, that the risk of a higher dollar and yields remained a headwind.

Meanwhile, adding to the uncertainty over the economic recovery was a recent spike in COVID-19 cases across major economies, including the U.S. and the UK, with worldwide infections crossing 37.74 million.

Silver XAG= fell 0.8% to $24.90 per ounce, platinum XPT= dipped 0.3% to $870.75, while palladium XPD= rose 0.6% to $2,416.51.
Reporting by Eileen Soreng and Nakul Iyer in Bengaluru; Editing by Rashmi Aich and Uttaresh.V

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.